EXTI - only public co. developing liver device Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : EXTI - only public co. developing liver device

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MaxLeverage who wrote (234)	3/9/1998 11:43:00 AM
From: Danny Kim	Read Replies (1) of 1063

Richard, I plan to frame all forward looking posts if EXTI does indeed take off. I recently read an article in the LA-Times (Friday or thursday), on their website, about USC and UCLA slated to receive approx $100M each! for biotech research from a person who owns several biotech companies in LA. One of his companies are doing research on artifical pancreas. Apparently there are many trade/investment organizations located in LA for biotech/artifical organ developmen. The article mentions some consortium of biotech companies locted in souther cal. I will try to locate the article and send it to EXTI. It seems to me partnering with one of these companies may get SYBIOL off the ground...though may not be the best financing option for EXTI but it would be better than no financing. ANythoughts out there?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next